CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade 23andMe Holding Co. - ME CFD

    0.91
    1.08%
    0.05
    Low: 0.91
    High: 0.94
    Market Trading Hours* (UTC) Open now
    Closes on Wednesday at 21:00

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.05
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026346 %
    Charges from full value of position ($-5.01)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026346%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004124 %
    Charges from full value of position ($0.78)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004124%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.93
    Open* 0.94
    1-Year Change* -70.16%
    Day's Range* 0.91 - 0.94
    52 wk Range 0.61-3.48
    Average Volume (10 days) 4.10M
    Average Volume (3 months) 73.16M
    Market Cap 413.61M
    P/E Ratio -100.00K
    Shares Outstanding 479.11M
    Revenue 270.18M
    EPS -0.73
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Feb 9, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 5, 2023 0.93 0.00 0.00% 0.93 0.95 0.89
    Dec 4, 2023 0.94 0.07 8.05% 0.87 0.97 0.87
    Dec 1, 2023 0.87 0.02 2.35% 0.85 0.90 0.81
    Nov 30, 2023 0.83 -0.05 -5.68% 0.88 0.89 0.83
    Nov 29, 2023 0.87 0.00 0.00% 0.87 0.91 0.83
    Nov 28, 2023 0.85 -0.03 -3.41% 0.88 0.88 0.83
    Nov 27, 2023 0.88 -0.02 -2.22% 0.90 0.90 0.86
    Nov 24, 2023 0.91 0.06 7.06% 0.85 0.91 0.85
    Nov 22, 2023 0.85 0.00 0.00% 0.85 0.85 0.82
    Nov 21, 2023 0.84 -0.02 -2.33% 0.86 0.86 0.81
    Nov 20, 2023 0.88 0.05 6.02% 0.83 0.90 0.82
    Nov 17, 2023 0.83 0.07 9.21% 0.76 0.84 0.75
    Nov 16, 2023 0.74 -0.10 -11.90% 0.84 0.84 0.73
    Nov 15, 2023 0.81 -0.03 -3.57% 0.84 0.86 0.81
    Nov 14, 2023 0.81 0.00 0.00% 0.81 0.85 0.78
    Nov 13, 2023 0.80 0.08 11.11% 0.72 0.84 0.71
    Nov 10, 2023 0.71 0.01 1.43% 0.70 0.73 0.69
    Nov 9, 2023 0.69 -0.17 -19.77% 0.86 0.86 0.69
    Nov 8, 2023 0.88 -0.01 -1.12% 0.89 0.90 0.86
    Nov 7, 2023 0.89 0.02 2.30% 0.87 0.89 0.84

    23andMe Holding Co. Events

    Time (UTC) Country Event
    Friday, February 9, 2024

    Time (UTC)

    21:05

    Country

    US

    Event

    Q3 2024 23andMe Holding Co. Earnings Release
    Q3 2024 23andMe Holding Co. Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total revenue 299.489 271.893 243.92 305.463 440.9
    Revenue 299.489 271.893 243.92 305.463 440.9
    Cost of Revenue, Total 164.993 138.948 126.914 168.031 248.01
    Gross Profit 134.496 132.945 117.006 137.432 192.89
    Total Operating Expense 623.5 526.046 429.116 563.91 629.683
    Selling/General/Admin. Expenses, Total 235.911 197.721 142.346 169.911 241.141
    Research & Development 222.596 189.377 159.856 181.276 140.532
    Unusual Expense (Income) 0 0 44.692 0
    Operating Income -324.011 -254.153 -185.196 -258.447 -188.783
    Interest Income (Expense), Net Non-Operating 9.676 0.277 1.577 7.584 5.25
    Net Income Before Taxes -314.428 -220.97 -183.619 -250.863 -183.533
    Net Income After Taxes -311.656 -217.49 -183.619 -250.863 -183.533
    Net Income Before Extra. Items -311.656 -217.49 -183.619 -250.863 -183.533
    Net Income -311.656 -217.49 -183.619 -250.863 -183.533
    Income Available to Common Excl. Extra. Items -311.656 -217.49 -183.619 -250.863 -183.533
    Income Available to Common Incl. Extra. Items -311.656 -217.49 -183.619 -250.863 -183.533
    Diluted Net Income -311.656 -217.49 -183.619 -250.863 -183.533
    Diluted Weighted Average Shares 451.504 361.528 43.4498 38.4538 34.4825
    Diluted EPS Excluding Extraordinary Items -0.69026 -0.60159 -4.226 -6.52376 -5.3225
    Diluted Normalized EPS -0.67591 -0.60159 -4.21449 -5.34333 -5.3225
    Other, Net -0.093 32.906
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 60.864 92.377 66.94 75.659 64.513
    Revenue 60.864 92.377 66.94 75.659 64.513
    Cost of Revenue, Total 30.184 52.395 36.189 37.386 39.023
    Gross Profit 30.68 39.982 30.751 38.273 25.49
    Total Operating Expense 170.128 161.651 164.04 143.7 154.109
    Selling/General/Admin. Expenses, Total 73.398 48.537 70.581 53.716 63.077
    Research & Development 62.329 60.719 57.27 52.598 52.009
    Unusual Expense (Income) 4.217
    Operating Income -109.264 -69.274 -97.1 -68.041 -89.596
    Interest Income (Expense), Net Non-Operating 4.307 4.369 3.671 1.392 0.245
    Other, Net 0.333 0.174 0.855 -0.687 -0.435
    Net Income Before Taxes -104.624 -64.731 -92.574 -67.336 -89.786
    Net Income After Taxes -104.624 -64.098 -91.961 -66.065 -89.532
    Net Income Before Extra. Items -104.624 -64.098 -91.961 -66.065 -89.532
    Net Income -104.624 -64.098 -91.961 -66.065 -89.532
    Income Available to Common Excl. Extra. Items -104.624 -64.098 -91.961 -66.065 -89.532
    Income Available to Common Incl. Extra. Items -104.624 -64.098 -91.961 -66.065 -89.532
    Diluted Net Income -104.624 -64.098 -91.961 -66.065 -89.532
    Diluted Weighted Average Shares 462.254 456.168 453.407 449.9 446.505
    Diluted EPS Excluding Extraordinary Items -0.22633 -0.14051 -0.20282 -0.14684 -0.20052
    Diluted Normalized EPS -0.21668 -0.14051 -0.18853 -0.14655 -0.20023
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total Current Assets 424.992 601.789 313.575 252.521
    Cash and Short Term Investments 386.849 553.182 282.489 207.942
    Cash 386.849 553.182 282.489 207.942
    Total Receivables, Net 1.897 3.38 2.481 6.392
    Accounts Receivable - Trade, Net 1.897 3.38 2.481 6.392
    Total Inventory 10.247 10.789 6.239 14.122
    Prepaid Expenses 19.224 25.139 15.485 13.088
    Other Current Assets, Total 6.775 9.299 6.881 10.977
    Total Assets 942.598 1152.07 452.098 404.63
    Property/Plant/Equipment, Total - Net 94.686 105.428 124.006 138.49
    Property/Plant/Equipment, Total - Gross 170.002 168.052 174.334 172.773
    Accumulated Depreciation, Total -75.316 -62.624 -50.328 -34.283
    Intangibles, Net 61.181 83.54 6.889 5.417
    Other Long Term Assets, Total 9.995 9.567 7.628 8.202
    Total Current Liabilities 149.416 153.241 121.619 139.448
    Accounts Payable 12.924 37.93 12.271 13.085
    Accrued Expenses 72.615 50.336 37.758 41.616
    Notes Payable/Short Term Debt 0 0 0 0
    Other Current Liabilities, Total 63.877 64.975 71.59 84.747
    Total Liabilities 228.659 236.412 210.366 270.43
    Total Long Term Debt 0 0 0 0
    Other Liabilities, Total 79.243 83.171 88.747 130.982
    Total Equity 713.939 915.656 241.732 134.2
    Redeemable Preferred Stock 0 837.351 755.083
    Common Stock 0.046 0.045 0 0
    Additional Paid-In Capital 2220.9 2110.16 381.619 172.736
    Retained Earnings (Accumulated Deficit) -1506.38 -1194.73 -977.238 -793.619
    Total Liabilities & Shareholders’ Equity 942.598 1152.07 452.098 404.63
    Total Common Shares Outstanding 461.2 448.812 54.2921 44.3183
    Total Preferred Shares Outstanding 91.1984 86.4433
    Goodwill, Net 351.744 351.744
    Other Equity, Total -0.62 0.179
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 297.995 360.276 424.992 508.671 506.205
    Cash and Short Term Investments 256.386 314.351 386.849 432.801 410.891
    Cash 256.386 314.351 386.849 432.801 410.891
    Total Receivables, Net 1.501 4.124 1.897 26.808 52.883
    Accounts Receivable - Trade, Net 1.501 4.124 1.897 26.808 52.883
    Total Inventory 14.979 11.815 10.247 11.96 13.806
    Prepaid Expenses 17.948 21.286 19.224 21.367 20.24
    Other Current Assets, Total 7.181 8.7 6.775 15.735 8.385
    Total Assets 801.23 871.199 942.598 1024.65 1040.73
    Property/Plant/Equipment, Total - Net 85.354 90.033 94.686 90.778 95.945
    Property/Plant/Equipment, Total - Gross 166.116 167.794 170.002 162.96 165.783
    Accumulated Depreciation, Total -80.762 -77.761 -75.316 -72.182 -69.838
    Intangibles, Net 56.806 59.56 61.181 63.185 76.435
    Other Long Term Assets, Total 9.331 9.586 9.995 10.276 10.403
    Total Current Liabilities 101.601 118.909 149.416 200.113 144.906
    Accounts Payable 8.546 12.748 12.924 13.984 10.549
    Accrued Expenses 51.899 56.695 72.615 75.624 51.233
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 41.156 49.466 63.877 110.505 83.124
    Total Liabilities 175.979 195.709 228.659 273.662 221.412
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 74.378 76.8 79.243 73.549 76.506
    Total Equity 625.251 675.49 713.939 750.992 819.32
    Redeemable Preferred Stock
    Common Stock 0.048 0.047 0.046 0.045 0.045
    Additional Paid-In Capital 2311.48 2287.41 2220.9 2193.54 2167.97
    Retained Earnings (Accumulated Deficit) -1686.28 -1611.01 -1506.38 -1442.29 -1350.32
    Total Liabilities & Shareholders’ Equity 801.23 871.199 942.598 1024.65 1040.73
    Total Common Shares Outstanding 478.831 472.096 461.2 457.161 455.453
    Goodwill, Net 351.744 351.744 351.744 351.744 351.744
    Other Equity, Total 0 -0.954 -0.62 -0.311 1.632
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Net income/Starting Line -311.656 -217.49 -183.619 -250.863 -183.533
    Cash From Operating Activities -165.39 -166.828 -74.252 -185.766 -98.117
    Cash From Operating Activities 32.071 23.699 18.078 22.249 9.901
    Amortization 4.427 2.449 2.168 1.04 0
    Non-Cash Items 125.725 16.23 71.396 42.724 52.952
    Changes in Working Capital -15.957 8.284 17.725 -0.916 22.563
    Cash From Investing Activities -11.305 -108.137 -6.536 -72.823 -27.84
    Capital Expenditures -11.31 -13.973 -7.374 -73.588 -27.84
    Other Investing Cash Flow Items, Total 0.005 -94.164 0.838 0.765 0
    Cash From Financing Activities 9.777 546.004 155.335 8.83 344.448
    Financing Cash Flow Items -0.89 -30.642 -3.316 0 -0.394
    Issuance (Retirement) of Stock, Net 10.667 576.646 158.651 8.83 344.842
    Net Change in Cash -166.533 270.893 74.547 -249.759 218.491
    Foreign Exchange Effects 0.385 -0.146
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -311.656 -247.558 -155.597 -89.532 -217.49
    Cash From Operating Activities -165.39 -120.429 -145.974 -73.04 -166.828
    Cash From Operating Activities 32.071 24.918 16.747 8.36 23.699
    Amortization 4.427 3.214 2.078 1.052 2.449
    Non-Cash Items 125.725 149.89 78.418 17.355 16.23
    Changes in Working Capital -15.957 -50.893 -87.62 -10.275 8.284
    Cash From Investing Activities -11.305 -8.017 -4.951 -2.9 -108.137
    Capital Expenditures -11.31 -8.017 -4.953 -2.9 -13.973
    Other Investing Cash Flow Items, Total 0.005 0 0.002 -94.164
    Cash From Financing Activities 9.777 7.171 7.182 1.533 546.004
    Financing Cash Flow Items -0.89 0 0 0 -30.642
    Issuance (Retirement) of Stock, Net 10.667 7.171 7.182 1.533 576.646
    Net Change in Cash -166.533 -120.581 -142.291 -73.784 270.893
    Foreign Exchange Effects 0.385 0.694 1.452 0.623 -0.146
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.9385 27256007 -306490 2023-06-30 LOW
    Newview Capital Management, LLC. Venture Capital 6.3804 19455681 0 2023-06-30 MED
    BlackRock Institutional Trust Company, N.A. Investment Advisor 5.6897 17349340 717618 2023-06-30 LOW
    Euclidean Capital, L.L.C. Investment Advisor 3.3592 10243122 0 2023-06-30 MED
    Fidelity Management & Research Company LLC Investment Advisor 2.2996 7012254 187220 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.0278 6183243 576924 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8421 5617120 254321 2023-06-30 LOW
    Sapphire Ventures, LLC Investment Advisor/Hedge Fund 1.7354 5291824 0 2023-06-30 MED
    Wojcicki (Anne) Individual Investor 1.0762 3281613 -312356 2023-07-10
    Renaissance Technologies LLC Hedge Fund 0.8227 2508729 977329 2023-06-30 HIGH
    Alibaba Group Holding Ltd. Corporation 0.6947 2118444 0 2023-06-30 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.6907 2106225 21160 2023-06-30 LOW
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.6692 2040726 -83543 2023-06-30 LOW
    Voya Investment Management LLC Investment Advisor/Hedge Fund 0.5418 1652033 726742 2023-06-30 LOW
    ACATIS Investment Kapitalverwaltungsgesellschaft GmbH Investment Advisor 0.4919 1500000 0 2023-06-30 LOW
    Morgan Stanley Investment Management Inc. (US) Investment Advisor/Hedge Fund 0.4368 1332011 -813862 2023-06-30 LOW
    Lovell (Evan M) Individual Investor 0.4029 1228544 1217077 2022-08-11
    Two Sigma Investments, LP Hedge Fund 0.3974 1211636 -995506 2023-06-30 HIGH
    Hibbs (Kathy L) Individual Investor 0.3754 1144697 0 2023-10-19 HIGH
    Selsavage (Joseph Anthony) Individual Investor 0.3657 1115162 1025992 2023-09-15 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    23andMe Holding Co. Company profile

    23andMe Holding Co. operates as a consumer genetics and research company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers'' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize promising drugs. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. The company was founded in 2006 and is headquartered in Sunnyvale, California.
    Industry: Medical & Diagnostic Laboratories

    349 Oyster Point Boulevard
    SOUTH SAN FRANCISCO
    CALIFORNIA 94080
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    XRP/USD

    0.64 Price
    +1.460% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    15,856.20 Price
    -0.080% 1D Chg, %
    Long position overnight fee -0.0263%
    Short position overnight fee 0.0041%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    BTC/USD

    44,119.40 Price
    +0.200% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Gold

    2,030.07 Price
    +0.480% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading